Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/subramanian-till-recently-had-opposed-india-on-ipr-4674330/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/subramanian-till-recently-had-opposed-india-on-ipr-4674330/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/subramanian-till-recently-had-opposed-india-on-ipr-4674330/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/subramanian-till-recently-had-opposed-india-on-ipr-4674330/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eff4137fc62-trace').style.display = (document.getElementById('cakeErr67eff4137fc62-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67eff4137fc62-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eff4137fc62-code').style.display = (document.getElementById('cakeErr67eff4137fc62-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eff4137fc62-context').style.display = (document.getElementById('cakeErr67eff4137fc62-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67eff4137fc62-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67eff4137fc62-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26292,
		&#039;title&#039; =&gt; &#039;Subramanian till recently had opposed India on IPR&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 25 October, 2014, http://timesofindia.indiatimes.com/india/Subramanian-till-recently-had-opposed-India-on-IPR/articleshow/44929094.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;subramanian-till-recently-had-opposed-india-on-ipr-4674330&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674330,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26292,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Subramanian till recently had opposed India on IPR&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;World Trade Organization,WTO,Compulsory license,Intellectual Property Rights,IRPs,medicines,patents&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26292,
	&#039;title&#039; =&gt; &#039;Subramanian till recently had opposed India on IPR&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 25 October, 2014, http://timesofindia.indiatimes.com/india/Subramanian-till-recently-had-opposed-India-on-IPR/articleshow/44929094.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;subramanian-till-recently-had-opposed-india-on-ipr-4674330&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674330,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26292
$metaTitle = &#039;LATEST NEWS UPDATES | Subramanian till recently had opposed India on IPR&#039;
$metaKeywords = &#039;World Trade Organization,WTO,Compulsory license,Intellectual Property Rights,IRPs,medicines,patents&#039;
$metaDesc = &#039;
-The Times of India


The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/subramanian-till-recently-had-opposed-india-on-ipr-4674330.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Subramanian till recently had opposed India on IPR | Im4change.org</title>
    <meta name="description" content="
-The Times of India


The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Subramanian till recently had opposed India on IPR</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify">The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.</p><p align="justify">Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&quot;</p><p align="justify">He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.</p><p align="justify">Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country's protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.</p><p align="justify">The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.</p><p align="justify">Instead, the US said there would be an out-of-cycle review of India's patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.</p><p align="justify">The fact that the person who is chief economic advisor has held positions that completely contradict India's stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India's patent laws.</p><p align="justify">In the same testimony before the congressional committee reviewing India's level of patent protection, Subramanian recommended that &quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&quot; and that &quot;India could commit to a stay on government-initiated compulsory licenses&quot;.</p><p align="justify">These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO's Trade Related Intellectual Properties (TRIPS) Agreement. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eff4137fc62-trace').style.display = (document.getElementById('cakeErr67eff4137fc62-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67eff4137fc62-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eff4137fc62-code').style.display = (document.getElementById('cakeErr67eff4137fc62-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eff4137fc62-context').style.display = (document.getElementById('cakeErr67eff4137fc62-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67eff4137fc62-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67eff4137fc62-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26292,
		&#039;title&#039; =&gt; &#039;Subramanian till recently had opposed India on IPR&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 25 October, 2014, http://timesofindia.indiatimes.com/india/Subramanian-till-recently-had-opposed-India-on-IPR/articleshow/44929094.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;subramanian-till-recently-had-opposed-india-on-ipr-4674330&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674330,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26292,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Subramanian till recently had opposed India on IPR&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;World Trade Organization,WTO,Compulsory license,Intellectual Property Rights,IRPs,medicines,patents&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26292,
	&#039;title&#039; =&gt; &#039;Subramanian till recently had opposed India on IPR&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 25 October, 2014, http://timesofindia.indiatimes.com/india/Subramanian-till-recently-had-opposed-India-on-IPR/articleshow/44929094.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;subramanian-till-recently-had-opposed-india-on-ipr-4674330&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674330,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26292
$metaTitle = &#039;LATEST NEWS UPDATES | Subramanian till recently had opposed India on IPR&#039;
$metaKeywords = &#039;World Trade Organization,WTO,Compulsory license,Intellectual Property Rights,IRPs,medicines,patents&#039;
$metaDesc = &#039;
-The Times of India


The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/subramanian-till-recently-had-opposed-india-on-ipr-4674330.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Subramanian till recently had opposed India on IPR | Im4change.org</title>
    <meta name="description" content="
-The Times of India


The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Subramanian till recently had opposed India on IPR</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify">The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.</p><p align="justify">Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&quot;</p><p align="justify">He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.</p><p align="justify">Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country's protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.</p><p align="justify">The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.</p><p align="justify">Instead, the US said there would be an out-of-cycle review of India's patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.</p><p align="justify">The fact that the person who is chief economic advisor has held positions that completely contradict India's stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India's patent laws.</p><p align="justify">In the same testimony before the congressional committee reviewing India's level of patent protection, Subramanian recommended that &quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&quot; and that &quot;India could commit to a stay on government-initiated compulsory licenses&quot;.</p><p align="justify">These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO's Trade Related Intellectual Properties (TRIPS) Agreement. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eff4137fc62-trace').style.display = (document.getElementById('cakeErr67eff4137fc62-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67eff4137fc62-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eff4137fc62-code').style.display = (document.getElementById('cakeErr67eff4137fc62-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67eff4137fc62-context').style.display = (document.getElementById('cakeErr67eff4137fc62-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67eff4137fc62-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67eff4137fc62-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26292,
		&#039;title&#039; =&gt; &#039;Subramanian till recently had opposed India on IPR&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 25 October, 2014, http://timesofindia.indiatimes.com/india/Subramanian-till-recently-had-opposed-India-on-IPR/articleshow/44929094.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;subramanian-till-recently-had-opposed-india-on-ipr-4674330&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674330,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26292,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Subramanian till recently had opposed India on IPR&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;World Trade Organization,WTO,Compulsory license,Intellectual Property Rights,IRPs,medicines,patents&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India


The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26292,
	&#039;title&#039; =&gt; &#039;Subramanian till recently had opposed India on IPR&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 25 October, 2014, http://timesofindia.indiatimes.com/india/Subramanian-till-recently-had-opposed-India-on-IPR/articleshow/44929094.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;subramanian-till-recently-had-opposed-india-on-ipr-4674330&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674330,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26292
$metaTitle = &#039;LATEST NEWS UPDATES | Subramanian till recently had opposed India on IPR&#039;
$metaKeywords = &#039;World Trade Organization,WTO,Compulsory license,Intellectual Property Rights,IRPs,medicines,patents&#039;
$metaDesc = &#039;
-The Times of India


The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &amp;quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &amp;quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&amp;quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country&#039;s protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Instead, the US said there would be an out-of-cycle review of India&#039;s patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The fact that the person who is chief economic advisor has held positions that completely contradict India&#039;s stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India&#039;s patent laws.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In the same testimony before the congressional committee reviewing India&#039;s level of patent protection, Subramanian recommended that &amp;quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&amp;quot; and that &amp;quot;India could commit to a stay on government-initiated compulsory licenses&amp;quot;.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO&#039;s Trade Related Intellectual Properties (TRIPS) Agreement. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/subramanian-till-recently-had-opposed-india-on-ipr-4674330.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Subramanian till recently had opposed India on IPR | Im4change.org</title>
    <meta name="description" content="
-The Times of India


The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Subramanian till recently had opposed India on IPR</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India</div><p align="justify">The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.</p><p align="justify">Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&quot;</p><p align="justify">He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.</p><p align="justify">Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country's protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.</p><p align="justify">The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.</p><p align="justify">Instead, the US said there would be an out-of-cycle review of India's patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.</p><p align="justify">The fact that the person who is chief economic advisor has held positions that completely contradict India's stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India's patent laws.</p><p align="justify">In the same testimony before the congressional committee reviewing India's level of patent protection, Subramanian recommended that &quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&quot; and that &quot;India could commit to a stay on government-initiated compulsory licenses&quot;.</p><p align="justify">These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO's Trade Related Intellectual Properties (TRIPS) Agreement. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 26292,
		'title' => 'Subramanian till recently had opposed India on IPR',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.
</p>
<p align="justify">
Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&quot;
</p>
<p align="justify">
He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.
</p>
<p align="justify">
Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country's protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.
</p>
<p align="justify">
The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.
</p>
<p align="justify">
Instead, the US said there would be an out-of-cycle review of India's patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.
</p>
<p align="justify">
The fact that the person who is chief economic advisor has held positions that completely contradict India's stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India's patent laws.
</p>
<p align="justify">
In the same testimony before the congressional committee reviewing India's level of patent protection, Subramanian recommended that &quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&quot; and that &quot;India could commit to a stay on government-initiated compulsory licenses&quot;.
</p>
<p align="justify">
These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO's Trade Related Intellectual Properties (TRIPS) Agreement. 
</p>',
		'credit_writer' => 'The Times of India, 25 October, 2014, http://timesofindia.indiatimes.com/india/Subramanian-till-recently-had-opposed-India-on-IPR/articleshow/44929094.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'subramanian-till-recently-had-opposed-india-on-ipr-4674330',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4674330,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 26292,
	'metaTitle' => 'LATEST NEWS UPDATES | Subramanian till recently had opposed India on IPR',
	'metaKeywords' => 'World Trade Organization,WTO,Compulsory license,Intellectual Property Rights,IRPs,medicines,patents',
	'metaDesc' => '
-The Times of India


The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes...',
	'disp' => '<div align="justify">-The Times of India</div><p align="justify">The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.</p><p align="justify">Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&quot;</p><p align="justify">He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.</p><p align="justify">Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country's protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.</p><p align="justify">The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.</p><p align="justify">Instead, the US said there would be an out-of-cycle review of India's patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.</p><p align="justify">The fact that the person who is chief economic advisor has held positions that completely contradict India's stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India's patent laws.</p><p align="justify">In the same testimony before the congressional committee reviewing India's level of patent protection, Subramanian recommended that &quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&quot; and that &quot;India could commit to a stay on government-initiated compulsory licenses&quot;.</p><p align="justify">These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO's Trade Related Intellectual Properties (TRIPS) Agreement. </p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 26292,
	'title' => 'Subramanian till recently had opposed India on IPR',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India
</div>
<p align="justify">
The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.
</p>
<p align="justify">
Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&quot;
</p>
<p align="justify">
He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.
</p>
<p align="justify">
Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country's protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.
</p>
<p align="justify">
The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.
</p>
<p align="justify">
Instead, the US said there would be an out-of-cycle review of India's patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.
</p>
<p align="justify">
The fact that the person who is chief economic advisor has held positions that completely contradict India's stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India's patent laws.
</p>
<p align="justify">
In the same testimony before the congressional committee reviewing India's level of patent protection, Subramanian recommended that &quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&quot; and that &quot;India could commit to a stay on government-initiated compulsory licenses&quot;.
</p>
<p align="justify">
These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO's Trade Related Intellectual Properties (TRIPS) Agreement. 
</p>',
	'credit_writer' => 'The Times of India, 25 October, 2014, http://timesofindia.indiatimes.com/india/Subramanian-till-recently-had-opposed-India-on-IPR/articleshow/44929094.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'subramanian-till-recently-had-opposed-india-on-ipr-4674330',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4674330,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {},
		(int) 6 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 26292
$metaTitle = 'LATEST NEWS UPDATES | Subramanian till recently had opposed India on IPR'
$metaKeywords = 'World Trade Organization,WTO,Compulsory license,Intellectual Property Rights,IRPs,medicines,patents'
$metaDesc = '
-The Times of India


The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes...'
$disp = '<div align="justify">-The Times of India</div><p align="justify">The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations.</p><p align="justify">Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, &quot;If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India.&quot;</p><p align="justify">He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, &quot;the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions&quot;. Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year.</p><p align="justify">Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country's protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months.</p><p align="justify">The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year.</p><p align="justify">Instead, the US said there would be an out-of-cycle review of India's patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now.</p><p align="justify">The fact that the person who is chief economic advisor has held positions that completely contradict India's stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India's patent laws.</p><p align="justify">In the same testimony before the congressional committee reviewing India's level of patent protection, Subramanian recommended that &quot;India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law&quot; and that &quot;India could commit to a stay on government-initiated compulsory licenses&quot;.</p><p align="justify">These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO's Trade Related Intellectual Properties (TRIPS) Agreement. </p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Subramanian till recently had opposed India on IPR

-The Times of India The man who has been appointed the chief economic advisor to the government of India, Arvind Subramanian, was until recently urging the US to initiate disputes against India before the World Trade Organisation and also seeking changes in provisions within Indian patent law aimed at preventing frivolous patenting and preventing pharma companies from getting extensions on patents by tweaking existing drugs and passing them off as innovations. Subramanian was a senior fellow at the Peterson Institute for International Economics and at the Center for Global Development. As recently as March this year, in a written testimony submitted during the process of review by the US of intellectual property (IP) protection of various countries including India, Subramanian wrote, "If India does not address the problems created by Section 3(d) of the patent legislation or by compulsory licensing for nonworking, the United States should consider initiating WTO disputes against India." He justified this approach on the ground that India took its WTO obligations seriously and had a good track record of implementing WTO dispute settlement rulings. He added that for the US, "the virtue of using WTO dispute settlement was that it would be diplomatically and politically less confrontational than unilateral and bilateral actions". Subramanian was reiterating a position he had taken in an earlier testimony to the US Congress in March last year. Every year the US brings out a report, under section 301 of its Trade Act, which categorises countries according to their level of intellectual property protection. If a country's protection level is deemed inadequate, it is categorized as a priority foreign country (PFC), a situation that could lead to US trade sanctions if not resolved within 6 months. The legality of such a unilateral action has been questioned under the WTO, though industrial lobbies in the US have been asking the US government to place India in the PFC category. However, the US stopped short of placing India in this category in its report earlier this year. Instead, the US said there would be an out-of-cycle review of India's patent protection measures. Currently, the US is inviting submissions for the out-of-cycle review that is happening now. The fact that the person who is chief economic advisor has held positions that completely contradict India's stance on patents has been a matter of concern among those arguing in favour of the provisions for protection of public health within India's patent laws. In the same testimony before the congressional committee reviewing India's level of patent protection, Subramanian recommended that "India could consider eliminating the additional efficacy requirement for patentability in Section 3 (d) of its patent law" and that "India could commit to a stay on government-initiated compulsory licenses". These recommendations are in line with the demands of the US pharmaceutical industry, which has been lobbying against compulsory licencing and demanding the dilution of section 3(d) of the Indian patent law, though India insists it is well within the flexibilities allowed under the WTO's Trade Related Intellectual Properties (TRIPS) Agreement.